Syringes & Injection Needle Manufacturing in the US - Industry Market Research Report

Sticking it: The number of adults aged 65 and older is forecast to increase, boosting industry demand

Over the past five years, syringe and needle manufacturers have faced declining demand and revenue amid a decrease in nonessential medical treatments following the onset of the COVID-19 pandemic. Still, larger companies were able to capture spiking demand for syringes specifically designed to administer vaccines, leading to an uptick in revenue in 2021. Many have faced compressing profit as workforces continue to expand in an effort by major manufacturers to bring new innovative products to market. Industry-wide revenue has been falling at a CAGR of 1.9% over the past five years and is expected to total $3.4 billion in 2023, when revenue will jump by an estimated 6.5%.

Establishments in this industry manufacture a variety of syringes and injection needles, including hypodermic syringes, medical bulb syringes, blood collection syringes and fountain syringes. Typically, industry products include a barrel, plunger, needle and cap. This industry excludes syringes used for nonmedical purposes.

This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry's key players and their market shares.